As of 2025-07-16, the Intrinsic Value of Calumet Specialty Products Partners LP (CLMT) is 24.28 USD. This CLMT valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 16.38 USD, the upside of Calumet Specialty Products Partners LP is 48.20%.
The range of the Intrinsic Value is 7.17 - 75.62 USD
Based on its market price of 16.38 USD and our intrinsic valuation, Calumet Specialty Products Partners LP (CLMT) is undervalued by 48.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 7.17 - 75.62 | 24.28 | 48.2% |
| DCF (Growth 10y) | 17.99 - 100.88 | 38.91 | 137.5% |
| DCF (EBITDA 5y) | 6.28 - 36.03 | 14.21 | -13.2% |
| DCF (EBITDA 10y) | 14.42 - 50.33 | 24.83 | 51.6% |
| Fair Value | -22.17 - -22.17 | -22.17 | -235.32% |
| P/E | (44.07) - (55.33) | (48.76) | -397.7% |
| EV/EBITDA | (115.81) - 2.48 | (67.38) | -511.4% |
| EPV | (24.19) - (21.60) | (22.90) | -239.8% |
| DDM - Stable | (34.79) - (127.99) | (81.39) | -596.9% |
| DDM - Multi | 7.69 - 23.19 | 11.71 | -28.5% |
| Market Cap (mil) | 1,418.84 |
| Beta | 1.67 |
| Outstanding shares (mil) | 86.62 |
| Enterprise Value (mil) | 3,984.14 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.52% |
| Cost of Debt | 8.65% |
| WACC | 8.93% |